Law ❯ Litigation ❯ Class Action
Investor Rights Moderna, Inc. REGENXBIO, Inc. Lululemon Athletica Inc. CVS Health Corporation ImmunityBio, Inc. XPEL, Inc. DeFi Technologies, Inc. Dow Inc. Securities Eos Energy Enterprises, Inc.
Plaintiffs say early revenue recognition concealed weakening demand, triggering later disclosures that drove sharp share declines.